1. Home
  2. OCC vs MAIA Comparison

OCC vs MAIA Comparison

Compare OCC & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Optical Cable Corporation

OCC

Optical Cable Corporation

HOLD

Current Price

$7.24

Market Cap

48.8M

Sector

Industrials

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.53

Market Cap

89.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCC
MAIA
Founded
1983
2018
Country
United States
United States
Employees
N/A
13
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.8M
89.7M
IPO Year
2001
2022

Fundamental Metrics

Financial Performance
Metric
OCC
MAIA
Price
$7.24
$1.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
121.8K
1.1M
Earning Date
06-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
290.91
29.53
EPS
N/A
N/A
Revenue
$87,828,590.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.03
N/A
52 Week Low
$2.40
$0.87
52 Week High
$11.50
$3.19

Technical Indicators

Market Signals
Indicator
OCC
MAIA
Relative Strength Index (RSI) 59.54 38.48
Support Level $4.35 $1.20
Resistance Level $9.89 $1.66
Average True Range (ATR) 0.84 0.16
MACD 0.12 -0.05
Stochastic Oscillator 48.20 13.43

Price Performance

Historical Comparison
OCC
MAIA

About OCC Optical Cable Corporation

Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: